Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chromosome 19 open reading frame 47 (C19orf47) is a human protein-coding gene that encodes a 422-amino acid protein, primarily located in the nucleoplasm and nucleus of the cell[1][5]. C19orf47 is broadly expressed in heart, testes, and other tissues[1]. It is uncharacterized in terms of defined biological function or molecular pathway and does not belong to classic protein families such as receptors, enzymes, transporters, or transcription factors[1][7][8]. C19orf47 is not established as a therapeutic or pharmacological target. It has predicted protein–protein interactions with molecules involved in RNA processing and export (such as DDX39B, NXF1, THOC2), and proto-oncogenes (for example, MYC)[1]. There is no evidence of direct disease association, drug interaction, or biomarker use. While a variant was found in one family affected by a rare neurological disorder (dystonia), C19orf47 is not regarded as pathogenic, and other genes were more likely causal[1]. The protein is conserved across a wide range of species but remains functionally uncharacterized[1][5][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chromosome 19 open reading frame 47 (C19orf47).